Open Accessibility Menu
Hide

Noelene Pang, MD

  • NPI Number: 1396927729
  • Primary Specialty: Ophthalmology
  • Languages Spoken: English
  • Gender: Female

About

A native Southern Californian, Dr. Pang received her Medical Doctorate from Loma Linda University School of Medicine, where she was recognized for her contributions to medical education with the Merck Award for Leadership. After internship at St. Joseph Hospital in Chicago, she attended ophthalmology residency at the prestigious Mayo Clinic in Rochester, Minnesota, and served as Co-Chief Resident in her final year.

An accomplished artist and scientist, Dr. Pang started her education with Bachelor Degrees in both Art and Biology and graduated summa cum laude with honors from La Sierra University in Riverside, California. To combine her dual interests in the arts and sciences, Dr. Pang completed a competitive two-year fellowship in oculoplastic and facial aesthetic surgery accredited by the American Society of Ophthalmic Plastic and Reconstructive Surgery (www.ASOPRS.org) at the University of Toronto. ASOPRS has distinguished her with the Marvin Quickert Thesis Award for her research excellence, an award reserved for the most outstanding research in the society.

Throughout her academic career, she has trained and mentored medical students, residents, and fellows at the Mayo Clinic, University of Toronto, and University of Oklahoma. She has also authored several articles in peer-reviewed journals and has presented numerous scientific papers at national and international meetings. To balance her life, she enjoys medical missions, travel, theater, dance, and music performance.

As an ASOPRS fellowship-trained oculoplastic surgeon and a board-certified Fellow of the American Academy of Ophthalmology, Dr. Pang specializes in cosmetic and reconstructive eyelid surgery, lacrimal and orbital surgery, facial aesthetic surgery, and skin rejuvenation using chemical peels, BOTOX®, and injectable fillers. She also has an interest in eyelid, lacrimal, and orbital disease management, including blepharospasm, eyelid malformations, tearing disorders, and periocular tumors.

Age Groups Seen

  • Adult 21-65
  • Older Adult >65